Related Experiment Videos
Morphine clearance in children: does race or genetics matter?
Senthilkumar Sadhasivam1, Elke H J Krekels, Vidya Chidambaran
1Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Journal of Opioid Management
|September 4, 2012
Summary
African American children clear morphine faster than Caucasian children, impacting pain management. Further research is needed to personalize morphine analgesia based on race.
Area of Science:
- Pharmacology
- Pharmacogenetics
- Pediatric Medicine
Background:
- Interindividual variability in opioid response poses clinical challenges.
- Morphine is a common analgesic for pediatric perioperative pain.
- Factors like race and genetics influencing morphine disposition require further study.
Purpose of the Study:
- To investigate the impact of race on the pharmacokinetics of intravenous morphine in children.
- To explore the role of genetic variations in morphine disposition.
- To inform personalized pain management strategies.
Main Methods:
- A prospective, genotype-blinded observational pharmacokinetic study.
- 146 African American and Caucasian children undergoing elective adenotonsillectomy.
- Analysis of intravenous morphine pharmacokinetics and common UGT2B7 genetic variations.
Main Results:
- African American children exhibited higher morphine clearance compared to Caucasian children.
- Increased clearance was primarily linked to morphine-3-glucuronide formation.
- UGT2B7 genetic variations (2161C>T, 802C>T) did not explain the observed racial differences in clearance.
Conclusions:
- Child's race is a significant factor influencing perioperative intravenous morphine clearance.
- The findings highlight the need for further investigation into race-based personalization of morphine analgesia.
- Understanding these differences is crucial for optimizing pediatric pain management.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...